drugset / Trial / NCT01791894
Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma
NaSingle-groupOpen-labelBasic science
Summary
This pilot clinical trial studies arsenic trioxide in treating patients with basal cell carcinoma. Drugs used in chemotherapy, such as arsenic trioxide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stop them from dividing
Timeline
- Start
- 2013-04
- Primary completion
- 2013-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | arsenic trioxide | Small molecule | — | Intravenous |